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We used subtractive library screening to identify the changes that occur in gene expression during thyroid cell neoplastic
transformation. Complementary DNA from normal thyroid cells (HTC 2) was subtracted from a complementary DNA library
constructed from a human thyroid papillary carcinoma cell line. The library was screened for genes upregulated in human
thyroid papillary carcinoma cell line cells, and several cDNA clones were isolated. One of these clones has a sirtuin core and
high homology with the human silent information regulator protein family. This clone, designated ‘SIR-T8’, was overexpressed
in human thyroid carcinoma cell lines and tissues, but not in adenomas. The human SIR-T8 protein has a molecular weight of
39 kDa and is primarily located in the cytoplasm under the nuclear membrane. The SIR-T8 gene is located on chromosome
17q25-1.
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Malignant thyroid carcinomas deriving from follicular cells are
relatively rare in humans. They are divided into differentiated
tumours, which retain both structural and functional follicular cell
differentiation, and undifferentiated tumours, in which evidence of
differentiation is lacking. Undifferentiated carcinomas are rare,
rapidly progressive tumours. Differentiated tumours, which form
up to 90% of clinically detected thyroid carcinomas, are of two
main types: papillary carcinomas and follicular carcinomas. This
classiﬁcation was originally based on the dominant architectural
pattern of the tumour; it is now based on cytology, encapsulation,
distribution of metastasis and molecular biology ﬁndings (Hedin-
ger et al, 1989).
Studies from our laboratory and from other groups have helped
to identify the molecular events involved in thyroid carcinogenesis,
i.e., activation of the RET/PTC and of the TrkA tyrosine kinase
receptors in papillary carcinomas, activation of the ras genes by
point mutation and PPARg inactivation by fusion with PAX 8 in
follicular carcinomas (Kroll et al, 2000), and mutation of the p53
gene in anaplastic tumours (Pierotti et al, 1996; Fusco and Santoro,
1997). However, the mechanisms that regulate the process of trans-
formation of thyroid cells remain largely unknown. The
identiﬁcation of genes regulated by cell transformation, e.g. c-myc
(Cerutti et al, 1996), NFkB p65 (Visconti et al, 1997), HMGI-C
and HMGI (Y) (Chiappetta et al, 1995), galectin-1 (Chiariotti et
al, 1993), thymosin b-10 (Califano et al, 1998), has also provided
insight into the mechanisms regulating thyroid cell transformation.
In a previous screening of a subtractive complementary DNA
(cDNA) library resulting from a human thyroid carcinoma and
normal cell line, we identiﬁed the HIP gene, which is overexpressed
in malignant thyroid neoplasias (de Nigris et al, 1998).
Here we report the isolation of a novel gene, designated ‘SIR-T8’
because of its strong homology with human sirtuin proteins and
more in general with the silent information regulator (SIR) family
of proteins. The SIR proteins encompass a large number of genes
that have highly conserved structural homologous sequences in
organisms ranging from bacteria to man (Brachman et al, 1995;
Frye, 1999). Among them, the protein best characterised is SIR-2,
which belongs to a multigene family (Brachman et al, 1995; Frye,
1999; Sherman et al, 1999) that has been implicated in silencing,
chromosome stability, recombination (Brachman et al, 1995) and
decreased rate of ageing (Kaeberlein et al, 1999). This gene
attracted our attention because about 85% of all primary human
cancers has telomerase activity (Kim et al, 1994; Shay and
Bacchetti, 1997, Sprung et al, 1999). Attempts are underway to
identify clinical situations in which telomerase has diagnostic or
prognostic potential and to devise in situ techniques to distinguish
telomerase produced by normal vs cancer cells. Analysis of tumoral
and normal thyroid tissues shows that the SIR-T8 gene is overex-
pressed in all differentiated and undifferentiated thyroid
carcinomas cell lines and tissues examined. In contrast, its expres-
sion is weak or almost undetectable in all adenomas and normal
thyroid tissues analysed.
MATERIALS AND METHODS
Cell lines
The human thyroid carcinoma cell lines (NIM1, TPC-1, NPA,
WRO, ARO and FRO) are described elsewhere (Cerutti et al,
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HTC-2 cells were established and cultured as described (Curcio
et al, 1994). The human thyroid papillary carcinoma (NPA) cell
line was transfected according to the calcium-phosphate transfec-
tion protocol (Graham and van der Eb, 1973). Transfected cells
were selected in a medium containing G418 (400 mgm l
71).
Subtractive library construction and screening
A subtraction library was constructed enriching for NPA-speciﬁc
sequences with respect to normal thyroid-speciﬁc sequences as
described previously (de Nigris et al, 1998). Differential plaque
hybridization screening of the NPA(-NT) cDNA library was
performed according to a standard procedure (Sambrook et al,
1989). A human melanoma cDNA library constructed in Lambda
gt11 vector (Stratagene, La Jolla, CA, USA) was used to isolate
full-length cDNA. The library was screened according to protocols
provided by the manufacturer.
DNA sequencing and computer analysis
Positive phages from melanoma cDNA library screening were
puriﬁed from the phage lysate (Sambrook et al, 1989) and
digested with SalI. Inserts were subcloned in pBluescript II SK
(Stratagene) and automatically sequenced. The full-length amino
acid sequences were compared with sequence of the other
sirtuin using ‘Blast 2 sequences’ from the NCBI Blast website
(www.ncbi.nih.gov/gorf/bl.html). The European Molecular Biol-
ogy Laboratory/GenBank database was searched for known
sequences.
RNA extraction and Northern blot analysis
Total RNA was isolated from cultured cells with the guanidine
thiocyanate method, slightly modiﬁed (Sambrook et al, 1989).
Northern blot analysis, was performed according to standard
procedures (Sambrook et al, 1989). A 300 bp cDNA fragment of
the SIR-T8 gene was radiolabelled by the random primer method
(Feinberg and Vogelstein, 1983). Hybridisations were carried out
under stringent conditions according to standard procedures.
Hybridisation signals were normalised using a glyceraldehyde-phos-
phate-dehydrogenase (GAPDH) probe. The ﬁlters from normal
human and mouse embryo tissues were purchased from Clontech
(Palo Alto, CA, USA).
RT–PCR analysis of the SIR-T8 expression in thyroid
tumours
Five micrograms of total RNA digested with RNAse-free DNAse
were reverse transcribed using random exanucleotides as primers
(100 mM) and 12 units AMV reverse transcriptase (Promega);
0.2 mg of cDNA were ampliﬁed in 25 ml of the reaction mixture
containing 0.2 mM dNTPs, 1.5 mM MgCl2,4m M of each primer,
1 unit of Taq DNA polymerase (Perkin-Elmer) in Taq polymerase
buffer. After the ﬁrst denaturing step at 948C for 2 min, PCR
ampliﬁcation was performed for 30 cycles (948C for 50 s, 508C
for 50 s, 728C for 50 s). Sequences of forward and reverse primers
used were: 5'-TACCGGATCCAGCGTCTATCCAGACTAC-3' and
5'-CTCAGCTGGACGTCCGTATTCGAAGGTA-3'. In addition to
primers of the SIR-T8 gene, a set of primers designed to recognize
a cDNA for the constitutively expressed enzyme GAPDH was used
in each reaction as an internal control for the amount of cDNA
tested. The GAPDH speciﬁc primers were: forward 5'-ACATGTTC-
CAATATGATTCC-3' and reverse 5'-TGGACTCCACGACGTA-
CTCA-3' corresponding to nucleotides 195–215 and 355–335,
respectively (Tokunaga et al, 1987). The ampliﬁed products were
separated by 1.5% agarose gel electrophoresis and after Southern
blotting, hybridised with a SIR-T8 cDNA probe.
Construction of cDNA expression vector
The entire cDNA was digested from pBluescript using KpnI/BglII,
separated on 1% agarose gel, puriﬁed with a gel extraction kit
(Qiagen) and subcloned into the same sites of a mammalian
expression vector pFlag CMV (Stratagene). The cDNA was cloned
in-frame with a Flag epitope under the transcriptional control of
the cytomegalovirus promoter. This vector also carries the gene
for G418 resistance.
Immunoblotting and immunocytochemical analysis
Total protein extracts were prepared as described elsewhere
(Cerutti et al, 1996). Western blot was revealed with monoclonal
antibodies against the p/Flag epitope at 1 out of 200 dilution
(Sigma Chemical Co.). NPA cells were grown on coverslips for
24 h in DMEM supplemented with 5% foetal calf serum then
transfected; 24 h after transfection, the cells were brieﬂy rinsed with
PBS and ﬁxed with 3% (w v
71) paraformaldehyde in PBS for
15 min at room temperature and then permeabilised with 0.2%
Triton for 5 min. The coverslips were incubated with primary anti-
body in PBS for 1 h at 378C. After three rinses of 5 min each with
PBS, the cells were incubated with the second antibody, ﬂuores-
cein-conjugated antimouse IgG (Amersham Corp.) for 40 min at
378C. Unbound antibody was removed by several 5 min rinses at
room temperature with PBS prior to preparation for ﬂuorescence
microscopy.
Chromosome localisation
A human ﬁbroblast genomic library in the lFIXII vector (Strata-
gene) was screened at high-stringency conditions using the SIR-
T8 probe according to a standard procedure (Sambrook et al,
1989). Four phages were isolated. One was further characterised:
the insert was excised and sequenced. It shows identity with the
human SIR-T8 sequence. This phage was then used for FISH analy-
sis, which was performed as described previously (Veronese et al,
1995; Califano et al, 1998).
RESULTS
Construction and differential screening of a
cDNA subtractive library between NPA cells and
normal thyroid cells
A cDNA subtractive library between the NPA cell line, established
from a papillary human thyroid carcinoma, and HTC 2 cells from
normal thyroid tissue, was constructed enriching the NPA-speciﬁc
sequences, as previously described (de Nigris et al, 1998; see
Materials and Methods). Subsequently, this library was screened
by hybridisation of duplicated ﬁlters with cDNAs from poly(A)
+
mRNAs from NPA and HTC 2 cells, respectively. After three conse-
cutive screenings, we isolated 39 clones that gave rise to a much
stronger signal with the NPA probe than with the HTC 2 probe.
Six of these clones showed a 100% identity with a recently isolated
gene, designated ‘HIP’, which encodes a heparan sulphate/heparin-
binding protein. Four other clones showed a signiﬁcant homology
with a SIR-like protein family that encodes telomerase-related
proteins (Brachman et al, 1995). Northern blot analysis conﬁrmed
the presence of a 2.4 kb band about three-fold stronger in NPA
cells than in HTC-2 control cells and thyroid normal tissue
(P50.001 vs HTC-2 and N.T.) (Figure 1A).
Isolation and characterisation of a novel gene homologous
to SIR family protein and designated ‘SIR-T8’
The isolated cDNA contained an incomplete open reading frame.
Therefore, using the cDNA previously isolated as a probe, we
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Figure 1 Northern blot analysis of Sir-T8 expression. (A) Total RNA (5 mg per lane) was hybridised with SIR-T8 probe. Lane 1: normal thyroid cell line
HTC-2, lane 2: Normal tissue; and lane 3: NPA cell line. A GAPDH probe was used as internal control for uniform RNA loading. Lower part: densitometric
analysis. Bars present the mean+s.d. of the results obtained in three experiments. *P50.001 vs HTC-2 and normal thyroid tissue (NT). (B) cDNA and
amino acid sequences of SIR-T8. Nucleotides are numbered from the beginning of the sequence, and the deduced amino acid sequence is indicated from
the beginning of the open reading frame. An in-frame stop codon is indicated in bold. (C) Comparison of the amino acid sequence of SIR-T8 with other
known human SIR genes; the conserved domains are boxed.
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Twelve positive clones were isolated and the inserts were sequenced
(Figure 1B). The predicted amino acid sequences show a single
open reading frame of 945 bp, starting with ATG codon at
162 bp and ending with a stop codon TAG at nucleotides 1110
and 874 of the untranslated 3' end (Figure 1B). This open reading
frame encodes a protein of 315 amino acid residues that has a
calculated mass of 39 kDa.
A comprehensive search of the EMBL GenBank and the SWISS-
Protein data base revealed that the predicted amino acid sequence
was highly homologous to other known human sirtuin proteins
named ‘SIR-T’ (from 1 to 7) and had an 80% identity to protein
SIR-T7 (Frye, 2000). Our gene diverges from SIRT-7 in the 5' end,
but they have identical or similar amino acid residues scattered
throughout the sirtuin domain. In Figure 1C all known human
SIRT proteins are aligned and the conserved domain are boxed.
There are several amino acidic short motifs conserved within the
core domain: GAGISXXXGIPXXR, PXXXH, TQNID, HG; two sets
of CXXC that may be a zinc ﬁnger domain (Brachman et al, 1995).
The HG motif is of interest because a point mutation in this
domain causes loss of sirtuin-mediated ADP-ribosylation (Frye,
1999; Tanny et al, 1999).
Analysis of SIR-T8 gene expression in normal and tumoral
thyroid cells
To investigate whether SIR-T8 gene overexpression is a general
event in thyroid neoplastic transformation, we analysed its expres-
sion in other thyroid carcinoma cell lines of various tumour
histotypes by Northern blot. The following cell lines were exam-
ined: NIM 1, NPA and TPC-1 from papillary carcinomas; WRO
from a follicular carcinoma; and FRO and ARO from anaplastic
carcinomas. As shown in Figure 2, SIR-T8 expression was high
in all carcinoma cell lines and almost undetectable in normal
HTC-2 thyroid cells. SIR-T8 gene expression was particularly abun-
dant in ARO, WRO and FRO cells (ﬁve-fold vs HTC-2 P50.001)
and three-fold higher in NPA than in HTC-2 P50.05 (Figure 2,
lower panel).
Subsequently, we evaluated SIR-T8 gene expression in biopsies
from eight papillary carcinomas, three follicular carcinomas, six
anaplastic carcinomas and seven adenomas. SIRT-T8 expression
was very weak in normal thyroid and in adenomas (Figure 3, upper
panel), and abundant in most of the human differentiated papillary
and follicular thyroid carcinomas (Figure 3, middle panel) and
anaplastic carcinomas (Figure 3, lower panel).
SIR-T8 protein detection and subcellular localisation
To deﬁne the cellular localisation of the SIR-T8 protein, the full-
length cDNA was cloned in a pFlagCMV vector. The Flag epitope
identiﬁes the recombinant protein but not the endogenous form of
SIRT-8. This construct was transiently transfected in the NPA cell
line, which, because of its morphology and shape, makes it easier
to locate the recombinant protein. In NPA-transfected cells
Western blot revealed a 39 kDa protein that was not detectable
in NPA-untransfected cells (Figure 4, upper panel). NPA trans-
fected cells were ﬁxed with paraformaldehyde and stained with
anti-Flag antibodies. There was intense cytoplasmic staining in
the NPA-transfected cells (Figure 4B). At higher magniﬁcation
the signal was found to be localised to the perinuclear membrane
of NPA cells (Figure 4B).
SIR-T8 gene tissue distribution and chromosomal
localisation
Northern blot analysis of poly(A)
+ mRNAs from different human
tissues revealed three mRNA species: 3.5, 2.4 and 1.2 kb (Figure 5).
Gene expression was very weak in stomach and bone marrow. Also
spleen, brain, lung and kidney (Figure 5A) expressed low amounts
of SIR-T8. These transcripts diverge in their non-coding regions.
However, normal thyroid and carcinoma cell lines preferentially
express the 2.4 kb mRNA that drives 39 kDa protein synthesis.
To identify the human chromosomal location of the gene, we
screened a human ﬁbroblast genomic library with the SIR-T8 probe.
Four phages were isolated. The insert of one of these phages was
excised; a 3.0 kb fragment was subcloned by digestion and sequenced.
Because its sequence was identical to the cDNA sequence of SIR-T8,
this phage was used for FISH analysis, which showed that the SIR-T8
gene maps to chromosome 17q25-1 (Figure 6).
DISCUSSION
Differential screening of a subtractive library between a papillary
carcinoma cell line (NPA) and normal thyroid cells (HTC-2) led
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Figure 2 Expression of SIR-T8 in normal and tumoral thyroid cells. Total
RNA (5 mg per lane) was size-fractionated on denaturing formaldehyde
agarose gel, blotted onto nylon ﬁlters (hybond-N, Amersham) and probed
with SIR-T8 cDNA. RNA was fractioned from the following sources: lane 1:
normal thyroid primary culture cells; lane 2: NIM cell line; lane 3: TPC-1 cell
line; lane 4: NPA cell line; lane 5: WRO cell line; lane 6: FRO cell line; lane 7:
ARO cell line. A GAPDH probe was used as internal control for uniform
RNA loading. Lower panel: densitometric analysis of SIR-T8 expression.
Bars present the mean+s.d. of the results obtained in three experiments.
*P50.0001 vs HTC2, #P50.005 vs NPA and **P50.001 vs HTC2.
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Figure 3 SIR-T8 expression in normal and neoplastic thyroid tissues.
RT–PCR analysis of SIR-T8 in normal and neoplastic thyroid tissues. The
SIR-T8 mRNA was coampliﬁed with GAPDH as an internal control.
RNA sources were divided by pathology as indicated.
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in NPA cells. One of the clones corresponded to a novel gene;
therefore we isolated the entire cDNA. This cDNA encodes a
protein of 315 amino acids with a predicted molecular weight of
39 kDa. It is highly homologous to the sirtuin gene family that
comprises seven human genes, i.e. SIR-T 1–7. Consequently, we
called the gene 'SIR-T8’. Human SIR-T8 had a very high BLASTp
score with 85% identity in the core sirtuin domain to the SIR-T7
protein. The SIR-T8 protein has several short motifs of conserved
amino acids within the sirtuin core domain that is common to SIR
protein: the GAGISTXXGIPDFR sirtuin core motif, a GVWTL
motif at four residues from the C-terminus to the core motif that
is characteristic of class IV sirtuin, two sets of CXXC that may be
zinc ﬁnger domains and an HG motif that is strictly conserved in
all sirtuin proteins and that is probably involved in ADP ribosyla-
tion (Brachman et al, 1995). The enzymatic function of sirtuin is
not completely understood. The best characterised of the SIR
protein family is SIR-2 from yeast. It mediates histone deacetyla-
tion (Tanny et al, 1999) thereby suggesting a coupled reciprocal
activation mechanism involving interactions of SIR2 with NAD
and the N-acetl-lysine groups of acetylated histones (Imai et al,
2000; Landry et al, 2000).
Here, we report that SIR-T8 codes for a protein that is primarily
localised in the cytoplasm under the nuclear membrane. Con-
versely, most SIR proteins that have telomerase activity are in
the nucleolus (Morales et al, 1999). However, our ﬁnding is in
agreement with the subcellular localisation of other two SIR2-
related proteins: SIR2L and SIR2p Leishmania major is absent from
the nucleus (Zemzoumi et al, 1998).
SIR-T8 was overexpressed in seven carcinoma cell lines but
weakly detectable in normal thyroid cell line and tissue. The
expression of SIR-T8 was abundant in most of the human thyroid
carcinomas analysed. Expression was low or absent in normal thy-
roid cells tissues and benign adenomas. These results suggest that
SIR-T8 induction is a general event in thyroid cell transformation.
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Figure 5 Northern blot analysis of SIR-T8 gene in different normal tissues. SIR-T8 gene expression was analysed in Poly(A)
+ RNAs from various normal
tissues as indicated.
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Figure 4 Upper panel: Western blot analysis of protein SIR-T8. Total
protein extracts from the NPA cell line transfected and untransfected with
p/Flag-SIRT-8 construct were subjected to Western blot analysis with anti-
Flag monoclonal antibody. Lane 1: untransfected NPA cells; lane 2: NPA
cells transfected with the p/Flag-SIRT-8 construct; lane 3: COS cells trans-
fected with the p/Flag-SIRT-8 construct as control. Lower panel: Subcellular
localisation of SIR-T8. NPA cells were grown on coverslips for 24 h, trans-
fected with SIR-T8 expression vector and stained with Hoechst (A), or
immunostained with anti-Flag antibodies (B) as described.
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Figure 6 FISH mapping of the SIR-T8 gene to chromosome 17q25.1.
Left ideogram of chromosome 17. Right 4',6-diamidino2-phenylindole
(top) and corresponding propidium (bottom) FISH analysis of normal lym-
phocyte metaphase with a phage clone the SIR-T8 gene hybridisation. Note
the signal on chromosome 17q25.1.
SIR-T8 overexpression in thyroid carcinoma
F de Nigris et al
921
ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(6), 917–923Although the function of protein SIR-T8 needs to be deﬁned, by
analogy with the Sir 2 gene, SIR-T8 gene overexpression may play a
role in thyroid carcinogenesis. In fact, Sir 2 gene overexpression in
yeast causes chromosome instability and a loss in cell viability
(Holmes et al, 1997), and interactions between Sir 2 and other
SIR genes or histones induce the silenced chromatin state (Ivy et
al, 1986; Moretti et al, 1994). Moreover, these proteins modulate
the chromatin structure, thereby maintaining patterns of gene
expression throughout the development of multicellular organisms,
and they are required for telomere maintenance (Orlando and
Paro, 1995). Telomeres are specialised structures at the ends of
eukaryotic chromosomes. They are ribonucleoproteins that synthe-
size telomeric DNA on the chromosomal end using a segment of
its RNA as template. In most types of human somatic cells the telo-
meres shorten as with organism age and with repeated passages in
culture. The immortal cells that elude crisis are characterised by
stable levels of telomerase activity and by stable telomeres. This
suggests that telomerase activation can overcome the limitation
imposed by telomere length on the lifespan of cell lineages (Coun-
ter et al, 1992). In humans, telomerase activity is detectable in
germline cells and in certain stem cells, but not detectable in most
somatic cell lineages (Harley et al, 1997). It is also detected in most
human tumour samples analysed (Counter et al, 1994; Kim et al,
1994) suggesting that telomerase activation may represent an essen-
tial step in tumour progression. Moreover, increased expression of
the other telomerase proteins correlate with the metastatic pheno-
type (Sprung et al, 1999).
In conclusion, although the mechanism underlying enhanced
SIR-T8 gene expression in thyroid tumours is unknown, the
homology of SIR-T8 with the telomerase proteins, and its similarity
with telomerase proteins suggests its increased expression might
have a role in the process of thyroid carcinogenesis.
ACKNOWLEDGEMENTS
This work has been supported by grants from AIRC (Progetto
Speciale Oncosoppressori), the Progetto Finalizzato ‘Biotecnologie’o f
the CNR, by the Ministero della Ricerca Scientiﬁca e Tecnologica
(MURST) project ‘Piani di Potenziamento della Rete Scientiﬁca e
Tecnologica’. We thank the Associazione Partenopea per la Ricerche
Oncologiche (APRO) for its support. Dr Janete Cerutti was a
recipient of a fellowship from the Conselho Nacional de Desenvolvi-
mento Cientiﬁco e Tecnologico. F de Nigris was a recipient of a
fellowship from APRO. We are grateful to Jean Ann Gilder for
revising and editing the manuscript.
REFERENCES
Brachman CB, Sherman JM, Devine SE, Cameron EE (1995) The Sir2 gene
family, conserved from bacteria to humans, functions in silencing, cell
cycle progression, and chromosome stability. Gene Dev 9: 2888–2902
Califano D, Monaco C, Santelli G, Giuliano A, Veronese ML, Berlingieri MT,
de Franciscis V, Berger N, Trapasso F, Santoro M, Viglietto G, Fusco A
(1998) Thymosin b-10 Gene overexpression correlates with the highly
malignant neoplastic phenotype of transformed thyroid cells in vivo and
in vitro. Cancer Res 58: 823–828
Cerutti J, Trapasso F, Battaglia C, Zhang Li, Martelli ML, Berlingieri MT,
Fagin J, Santoro M, Fusco A (1996) Blockage of c-MYC protein synthesis
in human thyroid carcinoma cell lines reduces their growth in soft agar.
Clin Cancer Res 2: 119–126
Chiappetta G, Berlingieri MT, Manﬁoletti G, Santoro M, Bandiera A, Viscon-
ti R, Giancotti V, Fusco A (1995) The expression of the high mobility
group HMGI (Y) proteins correlates with the malignant phenotype of
human thyroid neoplasms. Oncogene 10: 1307–1314
Chiariotti L, Berlingieri MT, Berger N, De Rose P, Battaglia C, Bruni CB,
Fusco A (1993) Increased expression of the negative growth factor, galacto-
side binding protein gene in transformed thyroid cells and in human
thyroid carcinomas. Oncogene 7: 2507–2511
Counter CM, Avilion AA, Le Feuvre CE, Stewart NG, Greider CW, Harley
CB, Bacchetti S (1992) Telomere shortening associated with chromosome
instability is arrested in immortal cells which express telomerase activity.
EMBO J 11: 1921–1929
Counter CM, Hirte HW, Bacchetti S, Harley CB (1994) Telomerase activity in
human ovarian carcinoma. Proc Natl Acad Sci USA 91: 2900–2904
Curcio F, Ambesi-Impiombato FS, Perrella G, Coon HG (1994) Long-term
culture and functional characterization of follicular cells from adult normal
human thyroids. Proc Natl Acad Sci USA 91: 9004–9008
de Nigris F, Visconti R, Cerrutti J, Califano D, Mineo A, Santoro M, Santelli
G, Fusco A (1998) Overexpression of the HIP gene coding for a Heparin/
Heparan sulfate-binding protein in human thyroid carcinomas. Cancer Res
58: 54745–54751
Feinberg AB, Vogelstein B (1983) A technique for radiolabelling DNA restric-
tion endonuclease fragments to high speciﬁc activity. Anal Biochem 132:
613–619
Frye RA (1999) Characterization of ﬁve human cDNAs with homology to the
yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may
have protein ADP-ribosyltransferase activity. Biochem Biophys Res
Commun 260: 273–279
Frye RA (2000) Phylogenetic classiﬁcation of prokaryotic and eukaryotic
Sir2-like proteins. Biochem Biophys Res Commun 273: 793–798
Fusco A, Santoro M (1997) Human thyroid carcinogenesis. Forum 7.2: 214–
229
Graham FL, van der Eb AJ (1973) A new technique for the assay of infectivity
of human adenovirus 5 DNA. Virology 52: 456–467
Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD,
Bacchetti S, Hirte HW, Counter CM, Greider CW (1997) Telomerase, cell
immortality and cancer. Cold Spring Harb.. Symp Quant Biol 59: 307–315
Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classiﬁca-
tion of thyroid tumors a commentary on the second edition. Cancer 63:
908–911
Holmes SG, Rose AB, Steuerle K, Saez E, Sayegh S, Lee YM, Broach JR (1997)
Hyperactivation of the silencing proteins, Sir2p and Sir3p, causes chromo-
some loss. Genetics 145: 605–614
Imai SI, Armstrong CM, Kaeberlein M, Guarente L (2000) Transcriptional
silencing and longevity protein Sir2 is an NAD-dependent histone deace-
tylase. Nature 403: 795–800
Ivy JM, Klar AJS, Hicks JB (1986) Cloning and characterization of four SIR
genes of Saccharomyces cerevisiae. Mol Cell Biol 6: 688–702
Kaeberlein M, McVey M, Guarente L (1999) The SIR2/3/4 complex and SIR2
alone promote longevity in Saccharomyces cerevisiae by two different
mechanisms. Gene Dev 13: 2570–2580
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello
MG, Wright WE, Weinrich SL, Shay JW (1994) Speciﬁc association of
human telomerase activity with immortal cells and cancer. Science 266:
2011–2015
Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher
JA (2000) Pax8-PPARgamma1 fusion in oncogene human thyroid carcino-
ma. Science 289: 1357–1360
Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, Pillus L, Stermglanz R
(2000) The silencing protein SIR2 and its homologs are NAD-dependent
protein deacetylases. Proc Natl Acad Sci USA 97: 5807–5811
Morales CP, Holt SE, Ouelette M, Kaur KJ, Yan Y, Wilson KS, White MA,
Wright WE, Shay JW (1999) Absence of cancer-associated changes in
human ﬁbroblast immortalized with telomerase. Nature Genetics 21:
115–118
Moretti P, Freeman K, Coodly L, Shore D (1994) Evidence that a complex of
SIR proteins interact with the silencer and telomere-binding protein RAP-
1. Gene Dev 8: 2257–2269
Orlando V, Paro R (1995) Chromatin multiprotein complexes involved in the
maintenance of transcription patterns. Curr Opin Cell Biol 5: 174–179
Pierotti MA, Bongarzone I, Borello MG, Greco A, Pilotti S, Sozzi G (1996)
Cytogenetics and molecular genetics of carcinomas arising from thyroid
epithelial follicular cells. Genes Chrom Cancer 16: 1–14
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory
Manual. Cold Spring Harbor, NY: Cold Spring Harbor, Laboratory
M
o
l
e
c
u
l
a
r
a
n
d
C
e
l
l
u
l
a
r
P
a
t
h
o
l
o
g
y
SIR-T8 overexpression in thyroid carcinoma
F de Nigris et al
922
British Journal of Cancer (2002) 86(6), 917–923 ã 2002 Cancer Research UKShay JW, Bacchetti S (1997) A survey of telomerase activity in human cancer.
Eur J Cancer 5: 787–791
Sherman JM, Stone EM, Freeman-Cook LL, Brachman CB, Boeke JD, Pilus L
(1999) The conserved core of human SIR homologue functions in yeast
silencing. Mol Biol Cell 10: 3045–3059
Sprung NG, Sabatier L, Murnane JP (1999) Telomere dynamics in human
cancer cells. Exp Cell Res 247: 29–37
Tanny JC, Dowd GJ, Huang J, Hilz H, Moazed D (1999) An enzymatic activ-
ity in the yeast Sir2 protein that is essential for gene silencing. Cell 99:
735–745
Tokunaga K, Nakamura Y, Sakataka K, Fujimari K, Ohkuba M, Sawada K,
Sakiyama S (1987) Enhanced expression of glyceraldehyde-3-phosphate
dehydrogenase gene in human lung cancer. Cancer Res 21: 5616–5619
Veronese ML, Ohta M, Finan J, Nowell PC, Croce CM (1995) Detection of
myc translocation in lymphoma cells by ﬂuorescence in situ hybridization
with yeast artiﬁcial chromosomes. Blood 85: 2132–2138
Visconti R, Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K, Miano MP, de
Nigris F, Casalino L, Curcio F, Santoro M, Fusco A (1997) Expression of
the neoplastic phenotype by human thyroid carcinoma cell lines requires
NFkB p65 protein expression. Oncogene 15: 1987–1994
Zemzoumi K, Sereno D, Francois C, Guilvard E, Lemestre JL, Ouaissi A
(1998) Leishmania major: cell type dependent distribution of a 43 kDa
antigen related to silent information regulatory-2 protein family. Biol Cell
90: 239–245
M
o
l
e
c
u
l
a
r
a
n
d
C
e
l
l
u
l
a
r
P
a
t
h
o
l
o
g
y
SIR-T8 overexpression in thyroid carcinoma
F de Nigris et al
923
ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(6), 917–923